1. Amirifar, P., et al., Ataxia-telangiectasia: A review of clinical features and molecular pathology. 2019. 30(3): p. 277-288. 2. Shiloh, Y., ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer, 2003. 3(3): p. 155-68. 3. Reina-San-Martin, B., et al., ATM is required for efficient recombination between immunoglobulin switch regions. J Exp Med, 2004. 200(9): p. 1103-10. 4. Notarangelo, L.D., et al., Defects of classswitch recombination. Journal of Allergy and Clinical Immunology, 2006. 117(4): p. 855-864. 5. Qamar, N. and R.L. Fuleihan, The hyper IgM syndromes. Clinical reviews in allergy & immunology, 2014. 46(2): p. 120-130. 6. Reina-San-Martin, B., et al., ATM is required for efficient recombination between immunoglobulin switch regions. Journal of Experimental Medicine, 2004. 200(9): p. 1103- 1110. 7. Mohammadinejad, P., et al., Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM. Journal of Immunoassay and Immunochemistry, 2015. 36(1): p. 16-26. 8. Lumsden, J.M., et al., Immunoglobulin class switch recombination is impaired in Atmdeficient mice. Journal of Experimental Medicine, 2004. 200(9): p. 1111-1121. 9. Rothblum-Oviatt, C., et al., Ataxia telangiectasia: a review. Orphanet journal of rare diseases, 2016. 11(1): p. 159. 10. Noordzij, J.G., et al., Ataxia–telangiectasia patients presenting with hyper-IgM syndrome. Archives of disease in childhood, 2009. 94(6): p. 448-449. 11. Ghiasy, S., et al., The clinical significance of complete class switching defect in Ataxia telangiectasia patients. Expert review of clinical immunology, 2017. 13(5): p. 499-505. 12. Van Os, N.J., et al., Ataxia-telangiectasia: immunodeficiency and survival. Clinical Immunology, 2017. 178: p. 45-55. 13. Suarez, F., et al., Incidence, presentation, and prognosis of malignancies in ataxiatelangiectasia: a report from the French national registry of primary immune deficiencies. J Clin Oncol, 2015. 33(2): p. 202-8.14. Azizi, G., et al., Autoimmunity in primary Tcell immunodeficiencies. Expert review of clinical immunology, 2016. 12(9): p. 989-1006.